IL138939D0 - A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof - Google Patents

A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Info

Publication number
IL138939D0
IL138939D0 IL13893999A IL13893999A IL138939D0 IL 138939 D0 IL138939 D0 IL 138939D0 IL 13893999 A IL13893999 A IL 13893999A IL 13893999 A IL13893999 A IL 13893999A IL 138939 D0 IL138939 D0 IL 138939D0
Authority
IL
Israel
Prior art keywords
truncate
polypeptide
uses
amino acid
binding protein
Prior art date
Application number
IL13893999A
Original Assignee
St Jude Childrens Res Hospital
Medimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US8087898P priority Critical
Priority to US09/056,019 priority patent/US6858706B2/en
Application filed by St Jude Childrens Res Hospital, Medimmune Inc filed Critical St Jude Childrens Res Hospital
Priority to PCT/US1999/007669 priority patent/WO1999051188A2/en
Publication of IL138939D0 publication Critical patent/IL138939D0/en

Links

IL13893999A 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof IL138939D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US8087898P true 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PCT/US1999/007669 WO1999051188A2 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
IL138939D0 true IL138939D0 (en) 2001-11-25

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13893999A IL138939D0 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Country Status (13)

Country Link
JP (1) JP4739521B2 (en)
CN (1) CN1191851C (en)
AU (2) AU3479699A (en)
BR (1) BR9909910A (en)
CA (1) CA2326388C (en)
HU (1) HU0102306A3 (en)
IL (1) IL138939D0 (en)
MX (1) MXPA00009899A (en)
NO (1) NO20005081L (en)
NZ (1) NZ507983A (en)
PL (1) PL193132B1 (en)
TR (1) TR200003498T2 (en)
WO (1) WO1999051188A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
KR101367237B1 (en) 2005-12-22 2014-03-14 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CN101784282B (en) 2007-06-26 2015-07-08 葛兰素史密丝克莱恩生物有限公司 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
WO2009127676A1 (en) 2008-04-16 2009-10-22 Glaxosmithkline Biologicals S.A. Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
EA201391456A1 (en) 2011-05-17 2014-05-30 Глаксосмитклайн Байолоджикалс С.А. VACCINE AGAINST Streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
DE69735715D1 (en) * 1996-05-01 2006-05-24 Rockefeller University New Yor Choline-binding protein, which is used as directed against pneumococcal vaccine
AT479756T (en) * 1996-10-31 2010-09-15 Human Genome Sciences Inc Streptococcus pneumoniae antigens and vaccines
EP0942984A2 (en) * 1996-11-12 1999-09-22 Qi Cheng C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
NZ507717A (en) * 1998-04-07 2004-02-27 Medimmune Inc Derivatives of pneumococcal choline binding proteins for vaccines
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Also Published As

Publication number Publication date
WO1999051188A9 (en) 2000-10-12
BR9909910A (en) 2002-01-15
AU3479799A (en) 1999-10-25
PL193132B1 (en) 2007-01-31
CA2326388A1 (en) 1999-10-14
NO20005081D0 (en) 2000-10-09
PL347946A1 (en) 2002-04-22
TR200003498T2 (en) 2001-10-22
WO1999051188A2 (en) 1999-10-14
JP4739521B2 (en) 2011-08-03
CN1342088A (en) 2002-03-27
CA2326388C (en) 2014-02-04
MXPA00009899A (en) 2002-05-08
JP2002516662A (en) 2002-06-11
HU0102306A2 (en) 2001-09-28
WO1999051188A3 (en) 2001-04-19
CN1191851C (en) 2005-03-09
HU0102306A3 (en) 2008-04-28
AU3479699A (en) 1999-10-25
NO20005081L (en) 2000-12-06
AU764811B2 (en) 2003-08-28
NZ507983A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
ZA9711239B (en) OB fusion protein compositions and methods.
EP2267009A3 (en) Activatable recombinant neurotoxins
EP1501863A4 (en) Kinase anchor protein muteins, peptides thereof, and related methods
CA2196419A1 (en) Improvements in or relating to binding proteins for recognition of dna
HU0004639A3 (en) Chlamydia protein, gene sequence and uses thereof
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
AU5947001A (en) Affinity selected signature peptides for protein identification and quantification
IL205233D0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
AU6198298A (en) Preparation of recombinant FVIII in a protein free medium
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
WO2003003984A9 (en) Novel proteins and nucleic acids encoding same
EP1371664A4 (en) Wti modified peptide
IL128229A (en) Peptide or protein covalently bound to pfg via the n-terminal, method of preparation of the same and pharmaceutical compositions comprising them
PT1090033E (en) Hcv envelope protein particles: used for vaccination
AU4140501A (en) Nucleic acids, proteins, and antibodies
GB9712892D0 (en) Identification of mhc binding peptides
EP1198250B8 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU6883298A (en) An engineered seed protein having a higher percentage of essential amino acids
AU1222901A (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
IL112873A (en) Rapamycin-fkbp12 binding proteins, their isolation and their use
EP1194164A4 (en) Prion protein peptides and uses thereof
IL125562A (en) Cyclic amino acids and pharmaceutical compositions comprising them
IL195649D0 (en) Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same
AU3633000A (en) Neutrokine-alpha binding proteins and methods based thereon
WO2003052057A3 (en) Egvi endoglucanase and nucleic acids encoding the same